The Senate Finance Committee plans to move ahead with a wide-ranging health care...
The Biden administration is slowly shifting millions of Covid-19 treatments to p...
The FDA said it has some safety concerns about an experimental CRISPR-based trea...
Sanofi, the Paris-based drug giant, announced that it would spin out its $5 bill...
From new hires to departures, transfers and promotions, here are the latest comi...
Want to stay on top of the science and politics driving biotech today? Sign up t...
The European Medicines Agency disclosed that its safety panel did not find a cau...
Prime Medicine says its refinement of CRISPR passed the major test of correcting...
"We look for the areas that we see our asymmetrical investment can really advanc...
An emergency room doctor celebrates the end of the fake medical condition “excit...
While much of the health care workforce is battling staff shortages, the emergen...
Men get breast cancer, too. The iconic pink ribbon needs a dash of blue to refle...
Over the past three years, Masimo has been engaged in a bitter legal battle with...
ISN-001 is under clinical development by Anterogen and currently in Phase II for...
Selinexor is under clinical development by Karyopharm Therapeutics and currently...
Itacitinib adipate is under clinical development by Incyte and currently in Phas...
